Process analysis of pluripotent stem cell differentiation to megakaryocytes to make platelets applying European GMP
Abstract Quality, traceability and reproducibility are crucial factors in the reliable manufacture of cellular therapeutics, as part of the overall framework of Good Manufacturing Practice (GMP). As more and more cellular therapeutics progress towards the clinic and research protocols are adapted to...
Guardado en:
Autores principales: | Moyra Lawrence, Amanda Evans, Thomas Moreau, Marta Bagnati, Matthew Smart, Enas Hassan, Jahid Hasan, Monica Pianella, Julie Kerby, Cedric Ghevaert |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec9c921fb0fa4a27a26eb34ffe692aee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming
por: Thomas Moreau, et al.
Publicado: (2016) -
The heterogeneity of megakaryocytes and platelets and implications for ex vivo platelet generation
por: Cuicui Liu, et al.
Publicado: (2021) -
Correction: Corrigendum: Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming
por: Thomas Moreau, et al.
Publicado: (2017) -
Platelet function is modified by common sequence variation in megakaryocyte super enhancers
por: Romina Petersen, et al.
Publicado: (2017) -
Assessment of a complete and classified platelet proteome from genome-wide transcripts of human platelets and megakaryocytes covering platelet functions
por: Jingnan Huang, et al.
Publicado: (2021)